The global demand for Artificial Intelligence In Precision Medicine Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Artificial intelligence in precision medicine is basically the use of genomic data to develop individually tailored diagnoses and treatments for patients. Artificial intelligence records the genomic data from different sources such as diagnostic imaging systems, electronic health records, prescriptions and genomic profiles etc. Many technologies such as hyper performance computing( HPC) and biological datasets, are vital for implementing precision medicine. Precision medicine helps in the identification of unique healthcare needs. AI assists in generating inside, enabling the system to learn and improve and support clinician decision-making.
Market Dynamics
The demand for artificial intelligence in precision medicine is scaling up due to growing rate of the generic population. An increase in the cases of respiratory diseases, along with the rising use of therapeutic respiratory devices, is surging the demand for this market. In addition, continuous improvement and advancement in cancer biology in emerging economies propel the demand for this market. Major companies are doing mergers, collaborations, acquisitions, and partnerships to enhance their market position. Furthermore, growth in research in development activities coupled with advancement in the healthcare sector augment the demand for this market. However high cost associated with precision medicines may restrict the growth of artificial intelligence in the precision medicine market.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of artificial intelligence in precision medicine. The growth and trends of artificial intelligence in precision medicine industry provide a holistic approach to this study.
Market Segmentation
This section of the artificial intelligence in precision medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Application
- Oncology
- Cardiology
- Neurology
- Respiratory
- Others
By Component
- Software
- Hardware
- Service
By Technology
- Deep Learning
- Natural Language Processing
- Querying Method
- Context Aware Processing
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Artificial Intelligence In Precision Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Artificial Intelligence In Precision Medicine Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the artificial intelligence in precision medicine market include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, Tempus Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
